Ombipepimut dosing emulsion (ODE) + bevacizumab (bev) vs bev alone in patients (pts) with recurrent or progressive glioblastoma (rGBM) von Goldlust, Samuel Aaron, Chang, Jong Hee, Narita, Yoshitaka, Welch, Mary Roberta, Green, Richard M., Drappatz, Jan, Piccioni, David Eric, Kim, Yu Jung, Melear, Jason M., Tanaka, Shota, Wei, Kuo-Chen, Fink, Karen L., Pitz, Marshall W., Cloughesy, Timothy Francis, de Groot, John Frederick, McClellan, Nanci, Hitron, Matthew, Xu, Bo, Jin, Bo, Lebedinsky, Claudia

Volltext